"Paliperidone Palmitate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A benzisoxazole derivative and active metabolite of RISPERIDONE that functions as a DOPAMINE D2 RECEPTOR ANTAGONIST and SEROTONIN 5-HT2 RECEPTOR ANTAGONIST. It is an ANTIPSYCHOTIC AGENT used in the treatment of SCHIZOPHRENIA.
| Descriptor ID |
D000068882
|
| MeSH Number(s) |
D03.383.129.385.650 D03.383.742.592
|
| Concept/Terms |
Paliperidone- Paliperidone
- 9-OH-risperidone
- 9 OH risperidone
- 3-(2-(4-(6-fluoro-3-(1,2-benzisoxazolyl))-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one
- 9-Hydroxy-risperidone
- 9 Hydroxy risperidone
- 9-Hydroxyrisperidone
- 9 Hydroxyrisperidone
|
Below are MeSH descriptors whose meaning is more general than "Paliperidone Palmitate".
Below are MeSH descriptors whose meaning is more specific than "Paliperidone Palmitate".
This graph shows the total number of publications written about "Paliperidone Palmitate" by people in this website by year, and whether "Paliperidone Palmitate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 3 | 0 | 3 |
| 2018 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Paliperidone Palmitate" by people in Profiles.
-
Beyond the Respiratory System: A Case Report Highlighting the Impact of COVID-19 in Mental Illness and Its Physical Consequences. J Clin Psychiatry. 2020 06 16; 81(4).
-
[Thoughts on a favourable evolution of a COVID-19 in a patient with resistant schizophrenia and on a combination of clozapine and paliperidone palmitate]. Encephale. 2020 Jun; 46(3S):S126-S127.
-
Predictive factors of overall functioning improvement in patients with chronic schizophrenia and schizoaffective disorder treated with paliperidone palmitate and aripiprazole monohydrate. Hum Psychopharmacol. 2018 05; 33(3):e2658.
-
Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines. Acta Psychiatr Scand. 2018 09; 138(3):196-222.
-
A randomized, 13-week study assessing the efficacy and metabolic effects of paliperidone palmitate injection and olanzapine in first-episode schizophrenia patients. Prog Neuropsychopharmacol Biol Psychiatry. 2018 Feb 02; 81:122-130.
-
The efficacy and tolerability of paliperidone in mania of bipolar disorder: A preliminary meta-analysis. Exp Clin Psychopharmacol. 2017 10; 25(5):422-433.
-
Paliperidone-Induced Hyponatremia. Prim Care Companion CNS Disord. 2017 Jul 27; 19(4).